{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:03:54Z","timestamp":1793865834202,"version":"4.6.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research","doi-asserted-by":"crossref","award":["15-34065A"],"award-info":[{"award-number":["15-34065A"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.cyto.2018.12.023","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T17:46:15Z","timestamp":1548438375000},"page":"13-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis"],"prefix":"10.1016","volume":"116","author":[{"given":"Lucie","family":"Andr\u00e9s Cerezo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Hulejov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"\u0160umov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Krop\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kry\u0161t\u016ffkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He\u0159man F.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Z\u00e1me\u010dn\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Pecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Vencovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.12.023_b0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00019052-199606000-00015","article-title":"The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis","volume":"9","author":"Dalakas","year":"1996","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.cyto.2018.12.023_b0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2044-5040-3-13","article-title":"Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness","volume":"3","author":"Rayavarapu","year":"2013","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.cyto.2018.12.023_b0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mayocp.2012.10.017","article-title":"Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations","volume":"88","author":"Ernste","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cyto.2018.12.023_b0020","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.41.6.936","article-title":"Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration","volume":"41","author":"Emslie-Smith","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2018.12.023_b0025","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2018.12.023_b0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.cyto.2018.12.023_b0035","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s13075-014-0468-2","article-title":"The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies","volume":"16","author":"Ple\u0161tilov\u00e1","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2018.12.023_b0040","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/rheumatology\/ker218","article-title":"The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies","volume":"50","author":"Cerezo","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2018.12.023_b0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cardiores.2007.03.027","article-title":"S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes","volume":"75","author":"Schneider","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cyto.2018.12.023_b0050","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0002-9440(10)63454-2","article-title":"Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases","volume":"163","author":"Seeliger","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2018.12.023_b0055","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar4311","article-title":"Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis","volume":"15","author":"Nistala","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2018.12.023_b0060","doi-asserted-by":"crossref","first-page":"18668","DOI":"10.1016\/S0021-9258(18)55115-2","article-title":"Purification, characterization, and partial sequence analysis of a newly identified EF-hand type 13-kDa Ca(2+)-binding protein from smooth muscle and non-muscle tissues","volume":"266","author":"Todoroki","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"413","key":"10.1016\/j.cyto.2018.12.023_b0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-5793(97)00911-3","article-title":"Annexin I targets S100C to early endosomes","volume":"11","author":"Seemann","year":"1997","journal-title":"FEBS Lett."},{"issue":"271","key":"10.1016\/j.cyto.2018.12.023_b0070","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1074\/jbc.271.2.719","article-title":"Calcium-dependent binding of S100C to the N-terminal domain of annexin I","volume":"12","author":"Mailliard","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2018.12.023_b0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/bj3190123","article-title":"Structural requirements for annexin I-S100C complex-formation","volume":"319","author":"Seemann","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.cyto.2018.12.023_b0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/bbrc.1999.1918","article-title":"Ca(2+)-dependent inhibition of actin-activated myosin ATPase activity by S100C (S100A11), a novel member of the S100 protein family","volume":"267","author":"Zhao","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"149","key":"10.1016\/j.cyto.2018.12.023_b0085","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1083\/jcb.149.6.1193","article-title":"Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts","volume":"12","author":"Sakaguchi","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cyto.2018.12.023_b0090","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00109-004-0560-1","article-title":"Introduction of an N-terminal peptide of S100C\/A11 into human cells induces apoptotic cell death","volume":"82","author":"Makino","year":"2004","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.cyto.2018.12.023_b0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrc3893","article-title":"S100 proteins in cancer","volume":"15","author":"Bresnick","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cyto.2018.12.023_b0100","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.4049\/jimmunol.175.12.8296","article-title":"Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products","volume":"175","author":"Cecil","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.12.023_b0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13075-017-1288-y","article-title":"Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis","volume":"19","author":"Andr\u00e9s Cerezo","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2018.12.023_b0110","doi-asserted-by":"crossref","first-page":"828354","DOI":"10.1155\/2013\/828354","article-title":"S100A8 and S100A9: DAMPs at the Crossroads between Innate Immunity, traditional Risk Factors, and Cardiovascular Disease","volume":"2013","author":"Schiopu","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2018.12.023_b0115","doi-asserted-by":"crossref","first-page":"e31490","DOI":"10.1371\/journal.pone.0031490","article-title":"The Gene Expression Analysis of Blood Reveals S100A11 and AQP9 as Potential Biomarkers of Infective Endocarditis","volume":"7","author":"Thuny","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2018.12.023_b0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1440-1827.2000.01069.x","article-title":"Isoproterenol-induced myocardial injury resulting in altered S100A4 and S100A11 protein expression in the rat","volume":"50","author":"Inamoto","year":"2000","journal-title":"Pathol. Int."},{"key":"10.1016\/j.cyto.2018.12.023_b0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2018.12.023_b0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2018.12.023_b0135","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kem045","article-title":"Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia","volume":"46","author":"Betteridge","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2018.12.023_b0140","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/rheumatology\/kem088","article-title":"The role of MRI in the assessment of polymyositis and dermatomyositis","volume":"46","author":"Tomasov\u00e1 Studynkov\u00e1 J, Charv\u00e1t F, Jarosov\u00e1 K, Vencovsky J","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2018.12.023_b0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-2999(96)00611-5","article-title":"Interaction of propranolol with S100 proteins of the cardiac muscle","volume":"315","author":"Nakatani","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cyto.2018.12.023_b0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1091\/mbc.e07-07-0682","article-title":"S100A11, an dual mediator for growth regulation of human keratinocytes","volume":"19","author":"Sakaguchi","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.cyto.2018.12.023_b0155","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1111\/febs.12378","article-title":"S100A11 is involved in the regulation of the stability of cell cycle regulator p21(CIP1\/WAF1) in human keratinocyte HaCaT cells","volume":"16","author":"Foertsch","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.cyto.2018.12.023_b0160","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11926-011-0169-7","article-title":"Malignancy in myositis","volume":"13","author":"Zahr","year":"2011","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cyto.2018.12.023_b0165","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1532-5415.2000.tb04719.x","article-title":"Epidemiology of sarcopenia","volume":"48","author":"Melton","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.cyto.2018.12.023_b0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-011-0176-8","article-title":"Antisynthetase syndrome","volume":"13","author":"Katzap","year":"2011","journal-title":"Curr. Rheumatol. Rep."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619300110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619300110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T23:59:00Z","timestamp":1662854340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466619300110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":34,"alternative-id":["S1043466619300110"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.12.023","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}